LRRK2 and alkaline phosphatase measurement: Patients with AP carried probably benign heterozygous variants, mainly in LRRK2 and PINK1. Pathogenic LRRK2 variants have been described in patients with primary tauopathies, although at a low frequency (Wen et al., 2021).